NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -52.6% | 16,916 | +61.9% | 0.00% | – |
| Q4 2018 | $19,000 | -96.8% | 10,448 | -97.6% | 0.00% | -100.0% |
| Q2 2018 | $595,000 | -35.0% | 444,150 | +1.9% | 0.00% | 0.0% |
| Q1 2018 | $915,000 | -78.9% | 435,755 | -26.9% | 0.00% | -80.0% |
| Q2 2016 | $4,332,000 | +116.5% | 595,806 | +53.7% | 0.01% | +150.0% |
| Q1 2016 | $2,001,000 | -37.5% | 387,735 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $3,202,000 | +18.0% | 382,910 | -0.2% | 0.00% | +33.3% |
| Q3 2015 | $2,713,000 | -36.4% | 383,660 | +0.2% | 0.00% | -40.0% |
| Q2 2015 | $4,265,000 | +31.8% | 382,910 | -2.2% | 0.01% | +25.0% |
| Q1 2015 | $3,237,000 | +144.5% | 391,470 | +75.4% | 0.00% | +300.0% |
| Q4 2014 | $1,324,000 | – | 223,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |